Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 3 March 2006. doi:10.1136/thx.2005.054643
Thorax 2006;61:514-520
Copyright © 2006 BMJ Publishing Group Ltd & British Thoracic Society.

CYSTIC FIBROSIS

Inducible NO synthase expression is low in airway epithelium from young children with cystic fibrosis

A Moeller1,2, F Horak, Jr1,4, C Lane1, D Knight6, A Kicic1,3, S Brennan5, P Franklin3, J Terpolilli1, J H Wildhaber2, S M Stick1

1 Department of Respiratory Medicine, Princess Margaret Hospital for Children, Perth, Western Australia
2 Division of Respiratory Medicine, University Children’s Hospital, Zurich, Switzerland
3 School of Paediatrics and Child Health, University of Western Australia, Nedlands, Western Australia
4 Department of General Pediatrics, University Children’s Hospital, Vienna, Austria
5 Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia, Western Australia
6 James Hogg iCAPTURE Centre for Cardiovascular and Respiratory Research, St Paul’s Hospital, Vancouver, BC, Canada

Correspondence to:
Dr A Moeller
Department of Respiratory Medicine, University Children’s Hospital Zurich, Steinwiesstrasse 75, CH-8032 Zurich, Switzerland; alexander.moeller{at}kispi.unizh.ch

Background: This is the first study to measure inducible nitric oxide synthase (iNOS) gene and protein expression quantitatively in primary epithelial cells from very young children with cystic fibrosis (CF). Low levels of exhaled nitric oxide (NO) in CF suggest dysregulation of NO production in the airway. Due to the importance of NO in cell homeostasis and innate immunity, any defect in the pathway associated with CF would be a potential target for treatment.

Methods: Cells were obtained by tracheobronchial brushing from 40 children with CF of mean (SD) age 2.1 (1.5) years and from 12 healthy non-atopic children aged 3.4 (1.2) years. Expression of iNOS mRNA was measured using quantitative PCR and iNOS protein by immunofluorescence and Western blot analysis.

Results: Inducible NOS mRNA expression was significantly lower in CF patients with and without bacterial infection than in healthy children (0.22 and 0.23 v 0.76; p = 0.002 and p = 0.01, respectively). Low levels of iNOS gene expression were accompanied by low levels of iNOS protein expression as detected by Western blot analysis.

Conclusions: These results support the findings of previous studies in adult patients with advanced disease, cell lines, and animal models. Our findings reflect the situation in children with mild lung disease. They indicate that low iNOS expression may be an innate defect in CF with potential consequences for local antimicrobial defence and epithelial cell function and provide evidence for an approach to treatment based on increasing epithelial NO production or the sensitivity of NO dependent cellular processes.

Abbreviations: BAL, bronchoalveolar lavage; CF, cystic fibrosis; cfu, colony forming units; iNOS, inducible NO synthase; NO, nitric oxide

Keywords: cystic fibrosis; inducible NO synthase; primary epithelial cells; infants


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Airwaves
Wisia Wedzicha
Thorax 2006 61: 459. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Brennan, S., Sly, P. D., Gangell, C. L., Sturges, N., Winfield, K., Wikstrom, M., Gard, S., Upham, J. W., on behalf of AREST CF, (2009). Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis. Eur Respir J 34: 655-661 [Abstract] [Full Text]  
  • McNamara, P. S., Kicic, A., Sutanto, E. N., Stevens, P. T., Stick, S. M. (2008). Comparison of techniques for obtaining lower airway epithelial cells from children. Eur Respir J 32: 763-768 [Abstract] [Full Text]  
  • Grasemann, C., Ratjen, F., Schnabel, D., Reutershahn, E., Vester, U., Grasemann, H. (2008). Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients. Eur Respir J 31: 815-821 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Chest Medicine Jobs

Chest Medicine Jobs